Evaluating expression of TAZ and YAP in multiple histological types of sarcoma revealed that approximately 50% of sarcoma clinical samples demonstrate activated YAP, while 66% demonstrate activated TAZ. The gene discussed is WWTR1; the disease is sarcoma.